Dishwasher Market Global Forecast Report by Product (Freestanding, Built-in) Application (Commercial, Residential) Distribution Channels (Offline, Online) Countries and Company Analysis, 2024-2032
Ltd, Astellas Pharma Inc., Baxter International Inc., Pfizer, and Dr. Reddy’s Laboratories Ltd are the main players in the Global Vitiligo Industry.
New pipeline treatments for vitiligo:
• Ritlecitinib (PF-06651600): An oral JAK3/TEC inhibitor developed by Pfizer, currently in Phase 3 trials.
• ATI-502: A topical JAK1/JAK3 inhibitor by Aclaris Therapeutics, in Phase 2 development.
• Cerdulatinib: A topical dual JAK/SYK inhibitor by Dermavant Sciences, undergoing Phase 2 trials.
• Roflumilast cream: A PDE4 inhibitor by Arcutis Biotherapeutics, in Phase 2 studies for vitiligo.
• IL-15 agonist: A novel approach by Immunocore, targeting melanocyte stimulation in preclinical stages.
• ARQ-252: A topical JAK1 selective inhibitor by Arcutis Biotherapeutics in early clinical development.
• VTP-38543: An LXRβ agonist by Vitae Pharmaceuticals aimed at promoting melanocyte differentiation.
• Afamelanotide: A synthetic hormone by Clinuvel Pharmaceuticals in late-stage trials for vitiligo.
• KB301: A gene therapy approach by Krystal Biotech designed to deliver functional TYR genes to melanocytes.
• VM206: A novel small molecule by Vilacto Bio targeting melanocyte regeneration in preclinical development.
By Diseases Type - Market is divided into 4 viewpoints
1. Segmental
2. Non-Segmental
Treatment Type - Market is divided into 4 viewpoints
1. Topical Treatments
2. Light Therapy
3. Surgical Procedures
4. Others
End User – Market is divided into 3 viewpoints
1. Hospitals
2. Ambulatory Clinics
3. Others
Country – 18 Country Vitiligo Patient Numbers & Market
1. United States
2. Canada
3. Mexico
4. Germany
5. United Kingdom
6. France
7. Italy
8. Spain
9. Japan
10. China
11. Australia
12. India
13. Brazil
14. Saudi Arabia
15. Argentina
16. United Arab Emirates
17. South Africa
18. Rest of World
Vitiligo Pipe Line Drugs
• AMG-714: Amgen
• ARN-4079
• ATI-502
• AX-1602
• BOS-475
• CCP-070
• Cerdulatinib (RVT-502)
• HuABC-2
• Abatacept
• Topical Ruxolitinib
• VLRX-001
Clinical Study of Vitiligo Market
Company Insight:
• Overviews
• Key Person
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue
Company Analysis
1. Incyte Corporation
2. Bristol-Myers Squibb
3. Clinuvel Pharmaceuticals Ltd
4. Astellas pharma inc
5. Baxter International Inc.
6. Pfizer
7. Dr. Reddy’s Laboratories Ltd